Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution. - sprookjes - yvandenbroek - TriplyDB

Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution.

Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution.

http://www.wikidata.org/entity/Q37036373

about

Progression of occupational risk management with advances in nanomaterials Gold nanoprobes for theranostics A comparison of immunotoxic effects of nanomedicinal products with regulatory immunotoxicity testing requirements Exosome-mediated small RNA delivery for gene therapy Critical questions in development of targeted nanoparticle therapeutics Peptides and proteins used to enhance gold nanoparticle delivery to the brain: preclinical approaches Nanoparticulate adjuvants and delivery systems for allergen immunotherapy Immunotoxicological impact of engineered nanomaterial exposure: mechanisms of immune cell modulation Multiple cues on the physiochemical, mesenchymal, and intracellular trafficking interactions with nanocarriers to maximize tumor target efficiency Immunosuppressive and anti-inflammatory properties of engineered nanomaterials Plasma proteins interaction with curcumin nanoparticles: implications in cancer therapeutics Stimulating antitumor immunity with nanoparticles A synthetic fibrin cross-linking polymer for modulating clot properties and inducing hemostasis.Functionalized iron oxide nanoparticles for controlling the movement of immune cells Value of phagocyte function screening for immunotoxicity of nanoparticles in vivo Engineered metal based nanoparticles and innate immunity Cytokines as biomarkers of nanoparticle immunotoxicity The dendritic cell response to classic, emerging, and homeostatic danger signals. Implications for autoimmunity Nanoparticles and direct immunosuppression The role of autophagy as a mechanism of toxicity induced by multi-walled carbon nanotubes in human lung cells Steering carbon nanotubes to scavenger receptor recognition by nanotube surface chemistry modification partially alleviates NFκB activation and reduces its immunotoxicity Nanoparticle Uptake: The Phagocyte Problem Realizing the clinical potential of cancer nanotechnology by minimizing toxicologic and targeted delivery concerns In Vivo Long-Term Biodistribution, Excretion, and Toxicology of PEGylated Transition-Metal Dichalcogenides MS2 (M = Mo, W, Ti) Nanosheets Facilitated monocyte-macrophage uptake and tissue distribution of superparmagnetic iron-oxide nanoparticles Zwitterionic chitosan derivative, a new biocompatible pharmaceutical excipient, prevents endotoxin-mediated cytokine release Effect of pullulan nanoparticle surface charges on HSA complexation and drug release behavior of HSA-bound nanoparticles Scalable hybrid chemical manufacture to photothermal therapy: PEG-capped phototransducers Nanotoxicity: An Interplay of Oxidative Stress, Inflammation and Cell Death Physically facilitating drug-delivery systems.Re-examining the size/charge paradigm: differing in vivo characteristics of size- and charge-matched mesoporous silica nanoparticles.Immunological properties of gold nanoparticles Nanoparticles and the immune system Targeted delivery of amikacin into granuloma.High drug-loading nanomedicines: progress, current status, and prospects.Ambiguities in applying traditional Limulus amebocyte lysate tests to quantify endotoxin in nanoparticle formulations.Mitigation of quantum dot cytotoxicity by microencapsulation Highly biocompatible TiO₂:Gd³⁺ nano-contrast agent with enhanced longitudinal relaxivity for targeted cancer imaging.Challenges associated with Penetration of Nanoparticles across Cell and Tissue Barriers: A Review of Current Status and Future Prospects.Induced T cell cytokine production is enhanced by engineered nanoparticles.

P2860

Q23923401-C70EACC7-F6CD-408B-8800-07C39AD3F46C Q24629197-ACAE4D85-25A1-493A-82A1-B00B24B4718C Q26744352-74D6CDB4-F7CB-4B58-9370-C48B7E933E6A Q26747740-F17C6B2B-5F2B-42E5-9B38-FF3F42DB7C56 Q26751896-4522FD9E-B44F-447C-B83A-F75191D6A232 Q26795570-105CE092-892D-4C24-B530-30675F49B783 Q26825418-411B19BC-AA01-482C-AB5D-7095CAF30936 Q26825654-13A04A05-BC0E-4A40-8F44-13E927844128 Q26827999-34E9047D-11A1-4A83-B00C-54DB396BD96A Q27005267-AA76A6F3-90B0-4138-A5F6-E8B681484A5E Q27026623-AAE6F904-623F-4948-BC79-2107313519F5 Q27027780-FEFCC90F-4A58-4EC2-B4B0-23C50D885AA8 Q27327667-EE284D24-71CD-49BF-9421-E647F1AB3A81 Q27336194-ADD710E4-3BF6-4956-9E1B-8B7553A95ED3 Q28084932-A814E1B0-BB86-4485-AFAD-6E881D6D59D0 Q28383470-C75FE0CA-3375-495C-9E92-BB8E6321F91C Q28383550-F99F3E8A-91E5-4705-B2A4-DC3DF3617484 Q28384138-6C12A851-B465-4138-880F-B6F2C286FC7E Q28384480-49969950-BD39-4C72-BABF-D903A706758D Q28386679-9269B537-8390-460F-8D6B-A4FBE7726622 Q28390421-8323FD58-A84D-48B6-A054-03CCE03908FC Q28395287-50DD3FD1-C60B-4E12-9BD4-9C52774EABDF Q28396462-42C844D6-61FD-44D2-9965-09834BFFA881 Q28468317-E99EC80B-5D07-4BE4-BD87-90C46B80C0E5 Q28474651-B0BB65B8-1F7F-4311-9E5B-0EBFB0A17E3C Q28479064-0B996520-6147-4FE7-AE53-0530AAAFCCBB Q28485162-A3B1B437-393B-4AE2-96CA-28A3B3E644BD Q28830834-CB067BBD-BED5-4D0F-93DB-6BF97B001DCC Q29248384-B8A11DDB-1F35-4400-B88D-3E6915899E5B Q30462003-74F26858-C563-4FE3-9DCC-623AF506AD6E Q30573652-5144FAB1-F23F-4C3B-BA45-061FD7F8F605 Q33578950-1807BC22-FCF3-40FD-B7CE-296C2B47AFA9 Q33634320-6AD1C444-4F4F-4CC0-BCA7-122C5DACD1C0 Q33652356-B194B4B7-BDED-438E-AE74-F5AA75F5FE00 Q33766568-FB858488-3448-4AD1-8D21-181871B4557F Q33975321-A87DD420-125C-4946-A5FB-6DECC0071FC8 Q33981469-62772805-FC62-4608-8AE4-96F1A5D6CD32 Q33997304-D810AB48-FE91-4B6C-8BA4-AC20535BFF6D Q34030709-DAEDBC5C-8479-4E8D-A1F4-5AF223513D4D Q34036445-7AB98BE0-672F-4B86-B853-C259C9AEB4A1

P2860

Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution.

http://www.wikidata.org/entity/Q37036373

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 30 May 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Preclinical studies to underst ...... nanoparticle biodistribution.

@en

Preclinical studies to underst ...... nanoparticle biodistribution.

@nl

type

label

Preclinical studies to underst ...... nanoparticle biodistribution.

@en

Preclinical studies to underst ...... nanoparticle biodistribution.

@nl

prefLabel

Preclinical studies to underst ...... nanoparticle biodistribution.

@en

Preclinical studies to underst ...... nanoparticle biodistribution.

@nl

P1433

Q37036373-653AAD66-4439-4BDB-A545-C7F9118DB33E

P1476

Q37036373-93F8BDCE-111D-44E1-B53C-901643FB0600

P2093

Q37036373-0C284BBC-F7EF-4BBE-AB1B-3889493D61E5

Q37036373-19DFE255-067F-4D62-B168-28DAD15C9A20

Q37036373-8E6369AA-3671-4789-93B8-7EE8E3D7C6F1

Q37036373-AF26A918-084A-4E3B-B012-45213D2DCD64

P2860

Q37036373-08911A40-7F66-488D-8C9D-9F62C6548F55

Q37036373-140572E9-A84D-4D04-8781-4D5D4DB931F5

Q37036373-1612C048-FF86-4D8C-B0A5-5150B9F1CA26

Q37036373-17111FEE-4453-4220-8EB0-5707DC1F1360

Q37036373-23016110-D102-4CA2-8C80-8D3E0F033C54

Q37036373-26D1935B-0DE1-41A5-9AC8-A4E9F974BF8A

Q37036373-307F216F-7271-483C-951E-1A278507D2A1

Q37036373-30F213A6-59B5-4A93-BD99-7DC1B5F59EBF

Q37036373-3FCE1B37-53AF-464E-A62B-86966BBC6C12

Q37036373-42A22CFA-2C2E-42C5-9CDB-0D40B3B24C6D

P304

Q37036373-9945FAED-4325-47F7-8CC3-9DCDD58DBF4C

P31

Q37036373-1E362007-480D-472E-A232-B9231F7B0B60

P356

Q37036373-7C4333F4-4FB6-4E17-936F-2AEA923922B9

P407

Q37036373-719BCFB8-C70E-4AF2-BF10-F5996BF93738

P433

Q37036373-1DCF9556-2F6F-4A53-83D9-D24EB069E72E

P478

Q37036373-9E8122B5-6DE9-4DAE-AA17-4720EF930DB7

P577

Q37036373-149FF6DF-CAB8-40B8-A25B-6FA0BC698758

P5875

Q37036373-82C59F53-B1B6-40F8-89CC-C442E7ADAE98

P698

Q37036373-CF9ED523-7E99-4DA7-BD95-519F7885212F

P921

Q37036373-2BFF10A8-F100-440A-9378-C1A6154BA0D1

P932

Q37036373-33EE2F89-4320-4845-A5E0-D300A4B73652

P356

P1433

Molecular Pharmaceutics

P1476

Preclinical studies to underst ...... nanoparticle biodistribution.

@en

P2093

Jennifer B Hall

http://www.w3.org/2001/XMLSchema#string

Marina A Dobrovolskaia

http://www.w3.org/2001/XMLSchema#string

Parag Aggarwal

http://www.w3.org/2001/XMLSchema#string

Scott E McNeil

http://www.w3.org/2001/XMLSchema#string

P2860

Platelet phagocytosis and aggregation

Nanoparticle-induced platelet aggregation and vascular thrombosis

Immunological properties of engineered nanomaterials

Development of phosphorylated glucomannan-coated chitosan nanoparticles as nanocarriers for protein delivery.

Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo.

Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles.

Gating the radical hemoglobin to macrophages: the anti-inflammatory role of CD163, a scavenger receptor.

Physicochemical and biological characterization of targeted, nucleic acid-containing nanoparticles.

The role of complement in inflammation and phagocytosis.

Characterization of nanoparticles for therapeutics.

P304

487-495

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/MP800032F

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2008-05-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5341314

http://www.w3.org/2001/XMLSchema#string

P698

18510338

http://www.w3.org/2001/XMLSchema#string

P921

P932

2613572

http://www.w3.org/2001/XMLSchema#string